JFrog insider reports planned 4,908-share sale; recent disposals total 35,875 shares
Rhea-AI Filing Summary
Form 144 notice for proposed sales of JFrog Ltd. (ticker: FROG) shows a planned sale of 4,908 common shares through Morgan Stanley Smith Barney with an aggregate market value of $232,094.37, to be executed approximately on 09/03/2025 on NASDAQ. The filer reports acquiring securities in September and August 2025 via performance shares (260), an employee stock purchase plan (326) paid in cash, and restricted stock (4,322). The notice lists four prior sales by the same person in the past three months totaling 35,875 shares with gross proceeds of $1,605,833.93 across dates from 06/02/2025 to 09/02/2025. The filing includes the required representation about lack of undisclosed material information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider is selling a modest block of shares after several recent disposals; transaction appears routine.
The Form 144 indicates an intended brokered sale of 4,908 common shares valued at $232,094.37 and discloses acquisitions and multiple recent dispositions by the same person totaling 35,875 shares and $1.61 million in gross proceeds. The filing provides transaction dates, types of acquisition (performance shares, ESPP, restricted stock) and payment methods where stated. The document lacks information on the filers relationship to the issuer and percentage ownership, which limits assessment of materiality. No other corporate events or financial results are included.
TL;DR: Disclosure meets Rule 144 format but provides limited context on insider status and ownership.
The submission follows Rule 144 structure by naming broker, planned sale date, and acquisition details for the securities to be sold. It also lists recent sales by the same individual over the prior three months and contains the standard signature representation about undisclosed material information. The filing does not state the filers relationship to the issuer or ownership percentage, which are relevant for evaluating compliance and the potential need for further disclosures.